AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising... Mid-Day - Published Also reported by •IndiaTimes •Hindu
[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious..
Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval.
Moderna will submit its
coronavirus vaccine on Nov. 30.
It is the second drugmaker to ask the FDA
for emergency use..
Credit: Wibbitz Top Stories Duration: 01:03Published
The Government could face some “tough choices” if the vaccine produced byAstraZeneca and Oxford University is found to be less effective than others, aformer Department of Health director of..
Credit: PA - Press Association STUDIO Duration: 00:59Published
![Moderna seeks U.S., EU vaccine authorization [Video]](https://video.newsserve.net/300/v/20201130/2011301838-Moderna-seeks-EU-vaccine-authorization.jpg)
![Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval [Video]](https://video.newsserve.net/300/v/20201130/1313844230-Moderna-to-Submit-COVID-19-Vaccine-for-FDA.jpg)
![Government could face ‘tough choices’ over vaccines [Video]](https://video.newsserve.net/300/v/20201127/2011271248-Government-could-face-tough-choices-over-vaccines.jpg)
